FQ
AGN

First Quadrant’s Allergan plc AGN Stock Holding History

First Quadrant’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-2,100
Closed -$307K – 773
2019
Q1 		$307K Hold
2,100
– – 0.02% 431
2018
Q4 		$281K Hold
2,100
– – 0.02% 463
2018
Q3 		$400K Hold
2,100
– – 0.01% 528
2018
Q2 		$350K Sell
2,100
-2,604
-55% -$418K 0.01% 535
2018
Q1 		$792K Sell
4,704
-1,700
-27% -$285K 0.02% 428
2017
Q4 		$1.05M Hold
6,404
– – 0.02% 432
2017
Q3 		$1.31M Buy
6,404
+969
+18% +$225K 0.03% 403
2017
Q2 		$1.32M Buy
5,435
+935
+21% +$220K 0.03% 395
2017
Q1 		$1.07M Sell
4,500
-1,900
-30% -$442K 0.02% 446
2016
Q4 		$1.34M Hold
6,400
– – 0.03% 406
2016
Q3 		$1.47M Sell
6,400
-200
-3% -$48.9K 0.03% 388
2016
Q2 		$1.52M Sell
6,600
-9,500
-59% -$2.19M 0.03% 328
2016
Q1 		$4.32M Buy
16,100
+1,362
+9% +$390K 0.09% 219
2015
Q4 		$4.61M Buy
14,738
+10,345
+235% +$3.08M 0.1% 217
2015
Q3 		$1.19M Sell
4,393
-734
-14% -$225K 0.03% 349
2015
Q2 		$1.56M Sell
5,127
-700
-12% -$209K 0.03% 313
2015
Q1 		$1.73M Buy
5,827
+77
+1% +$22K 0.04% 290
2014
Q4 		$1.48M Sell
5,750
-77
-1% -$19.2K 0.03% 309
2014
Q3 		$1.41M Sell
5,827
-56
-1% -$12.5K 0.03% 323
2014
Q2 		$1.31M Buy
5,883
+3,376
+135% +$699K 0.03% 346
2014
Q1 		$516K Sell
2,507
-1,333
-35% -$264K 0.01% 443
2013
Q4 		$645K Sell
3,840
-64,964
-94% -$10.2M 0.02% 430
2013
Q3 		$9.91M Sell
68,804
-2,600
-4% -$346K 0.25% 123
2013
Q2 		$9.01M Buy
+71,404
New +$8.08M 0.24% 128

Other funds holding AGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
LP
Longview Partners St Peter Port, Guernsey $7.06B AUM 3.43% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

First Quadrant's AGN Position: Q2 2019 in Review

First Quadrant sold out of Allergan plc (AGN) in Q2 2019, closing a stake of 2,100 shares — an estimated $307K sold.

First Quadrant first reported a position in AGN in Q2 2013 and held it in 24 quarters. The position peaked at $9.91M in Q3 2013. 970 funds tracked by Wall St. Rank hold AGN as of Q2 2019.

  • First Quadrant reported no remaining Allergan plc position as of Q2 2019 after selling out during the quarter.
  • First Quadrant sold 2,100 Allergan plc shares in Q2 2019, an estimated $307K.
  • First Quadrant first reported a position in Allergan plc in Q2 2013 and held it in 24 quarters.
  • First Quadrant's Allergan plc position peaked at $9.91M in Q3 2013.
  • 970 funds tracked by Wall St. Rank held Allergan plc as of Q2 2019.

Based on First Quadrant's 13F filing for Q2 2019, filed 24 Jul 2019.